 |
|
 |
Norway |
|
|
The Pharmaceutical Market: Norway
Publication Date March 2006
Publisher Espicom
Product Type Report
Pages 78
ISBN Number not applicable
Product Code ESP781
|
|
|
Summary
Although Norway is not part of the European Union, the process for pharmaceutical registration has been aligned to EU regulations. The relative ease of entry to the Norwegian market has enabled foreign companies to set up manufacturing plants, especially since the increased transparency in the pharmaceutical pricing structure.
Norway's pharmaceutical market is estimated to grow by 7.5% per annum to be reach US$4.1 billion by 2011. Due to the small scale of domestic production, increase in demand is likely to be met by imports. In 2004, imports were US$1.1 billion, an increase of 8.7% over 2003.
Since generic substitution was established in 2001, generic drugs have been able to gain an increasing share of the market, in terms of value and volume. In 2004, generics had 31.0% of sales and 47.6% of the market by volume.
These pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
|
Content
Background Data
- Geography
- Political Overview
- Economic Overview
- Population
- Population,
- Population by County,
- Demographic Indicators
- Mortality
- Morbidity
- Individually Notified Cases of Infectious Diseases,
- Tuberculosis
- Notified Cases of Tuberculosis by Site,
- Cancer
- New Cases of Cancer by Primary Site - Males, per 100,000 inhabitants,
- New Cases of Cancer by Primary Site - Females, per 100,000 inhabitants,
- HIV/AIDS
- HIV /AIDS cases,
- Charts
- Map of Norway
- Population by Age Group, 2005 (%)
- Chichester, West Sussex, PO20 2FS, United Kingdom
Healthcare System
- Organisation & Administration
- Health Expenditure
- Health Expenditure by Function, 2000-2004 (NOK millions)
- Health Service Expenditure by Source of Funding, 1999-2002 (NOK millions)
- Hospital Services
- Number of Health Institutions,
- Number of Beds by Type of Institution,
- Beds in Somatic Hospitals by Specialty,
- Elderly Care Beds
- Beds in Institutions for the Aged,
- Hospital Activity
- Patient Activity in Healthcare Institutions,
- Discharges from Somatic Hospitals by Diagnosis,
- Discharges from General Hospitals by Diagnosis,
- Day Cases
- General Hospital Day Cases,
- General Hospital Day Cases,
- Ambulatory Care
- Hospital Outpatient Care
- Outpatient Consultations,
- Medical Personnel
- Physicians by Specialty, June
- Dentists & Other Dentistry Staff,
- Chichester, West Sussex, PO20 2FS, United Kingdom
- Accessing The Pharmaceutical
- Market
- This page left intentionally blank
Accessing The Pharmaceutical Market
- Introduction
- Regulatory Environment
- Pharmaceutical Registration
- Patent Protection & Intellectual Property Rights
- Pricing and Reimbursement
- Pricing
- Reimbursement
- Distribution Channels
- Apokjeden AS
- Distributors
- Holtung AS
- Norsk Medisinaldepot AS
- Tamro Distribution AS
- Parallel Imports
- Parallel Imported Drug Sales,
- Domestic Production
- Trade Associations
- Domestic Producers
- Alpharma
- Nycomed Pharma AS
- Research & Development
- R&D Expenditure,
- Directory
|
|
|
